Sonidegib efficacy and tolerability in advanced basal cell carcinoma: A single-center real-life experience
Author:
Publisher
Elsevier BV
Subject
Dermatology
Reference4 articles.
1. Sonidegib: safety and efficacy in treatment of advanced basal cell carcinoma;Villani;Dermatol Ther (Heidelb),2020
2. Sonidegib and vismodegib in the treatment of patients with locally advanced basal cell carcinoma: a joint expert opinion;Dummer;J Eur Acad Dermatol Venereol,2020
3. Long-term efficacy of vismodegib after its withdrawal and patients' health-related quality of life using the dermatology life quality index (DLQI);Villani;Dermatol Ther (Heidelb),2019
4. Sonidegib for the treatment of advanced basal cell carcinoma: a comprehensive review of sonidegib and the BOLT trial with 12-month update;Chen;Future Oncol,2016
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. An update on the current and emerging pharmacotherapies for basal cell carcinomas;Expert Opinion on Pharmacotherapy;2023-11-18
2. Long-term strategies for management of advanced basal cell carcinoma with hedgehog inhibitors;Critical Reviews in Oncology/Hematology;2023-09
3. Multicenter Retrospective Andalusian Study of the Use of Sonidegib for the Treatment of Local Advanced Basal Cell Carcinoma in Real Clinical Practice;Journal of Clinical Medicine;2023-08-29
4. Sonidegib in Locally Advanced Basal Cell Carcinoma: A Monocentric Retrospective Experience and a Review of Published Real-Life Data;Cancers;2023-07-14
5. Efficacy and safety of sonidegib for the management of basal cell carcinoma: a drug safety evaluation;Expert Opinion on Drug Safety;2023-06-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3